Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/4/24 17:16 | 1/2/24 | RPRX | Health | Drug | Pharmaceutical Preparations | Riggs Rory B | NY | D | 3 | S.m | -75,739 | 32.09 | 0 | -2,360 | 1,557 | D | ||||||||||||||||
1/3/24 16:31 | 12/29/23 | RPRX | Health | Drug | Pharmaceutical Preparations | Avara Management Ltd | V8 | T | 4 | S.m | -28,670 | 28.67 | 0 | -1,000 | 32,883 | I | ||||||||||||||||
8/11/23 17:00 | 8/9/23 | RPRX | Health | Drug | Pharmaceutical Preparations | Coyne Terrance P. | NY | O | EVP,CFO | 2 | S.m | -4,630 | 30.87 | 0 | -150 | 915 | I | |||||||||||||||
6/6/23 17:07 | 6/2/23 | RPRX | Health | Drug | Pharmaceutical Preparations | Lloyd George W. | NY | O | EVP,Inve | 3 | S.m | -11,590 | 35.12 | 0 | -330 | 1,232 | I | |||||||||||||||
2/24/23 18:26 | 2/22/23 | RPRX | Health | Drug | Pharmaceutical Preparations | Urist Marshall | NY | O | EVP,Rese | 1 | S | -870 | 37.30 | 0 | -23 | 66 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |